Anticancer compounds and methods
AssigneeThe Regents of the University of Michigan
InventorDonna Livant
Life of this patent
Estimating the term…
Abstract
The testing of tumor cells, including human tumors capable of metastases, in assays employing fibronectin-depleted substrates is described. Ex vivo induction of cells, including biopsied human cells, is performed with invasion-inducing agents. Additionally, anti-cancer chemotherapeutics are described. Specifically, chemotherapeutic agents which have anti-metastatic and anti-growth properties are described including non-peptide compositions of matter.
Claims18
A composition comprising a dendrimer and at least one peptide comprising an amino acid sequence PHSCN (SEQ ID NO:86) attached to said dendrimer, wherein said dendrimer comprises branches.
A method, comprising:
- a) providing;
- i) a patient comprising a plurality of tumor cells;
- and
- ii) a composition comprising a dendrimer and at least one peptide comprising an amino acid sequence PHSCN (SEQ ID NO:86) attached to said dendrimer;
- and
- b) administering said composition to said patient under conditions such that at least a portion of said tumor cells undergo apoptosis.
A method, comprising:
- a) providing;
- i) a patient comprising a plurality of metastatic tumor cells;
- and,
- ii) a composition comprising a dendrimer and at least one peptide comprising an amino acid sequence PHSCN (SEQ ID NO:86) attached to said dendrimer, and;
- b) administering said composition to said patient under conditions such that metastatic acitivity by said tumor cells is inhibited.
Dependencies are inferred from the claim text.